Navigation Links
Totoku Europe Chooses Matrox Xenia(TM) Series to Drive Medical Monitors
Date:10/8/2008

MONTREAL, Oct. 8 /PRNewswire/ -- Matrox Graphics Inc., the leading manufacturer of specialized graphics solutions, confirms that Totoku Europe will be shipping Matrox Xenia(TM) Series display controller boards with its ME/CCL medical LCD displays.

Matrox Xenia is the first native PCI Express single-slot board with all-digital, triple-monitor output and the flexibility to drive practically any display configuration. Xenia Series supports resolutions from <1MP to 8MP with up to 1GB of on-board memory, and features new technology to ensure optimum display calibration (via Matrox DLC(TM) and 8/10/13-bit gamma). With additional development potential for increasing hardware-accelerated performance via hardware LUTs and multiple window IDs, Xenia Series is a flexible and expandable solution for medical imaging professionals.

Backed by more than 30 years experience in display innovation, Totoku medical monitors deliver high resolution, high luminance, and ultra-crisp images. Medical professionals will have the opportunity to see Totoku+Xenia solutions at MEDICA'08 in the Rein MeDiSol / Totoku booth (Hall 15, #32)

"We are pleased to offer Xenia Series with Totoku displays to our partners in Europe, Middle East and Africa," says Dirk Cordt, general manager sales and marketing of Totoku Europe. "The combination of this high performance board with our actual range of Diagnostic Displays including 15MP and High Brightness Solutions will show remarkable overall performance. This was confirmed by all attendees at our recent International Partner meeting in Dusseldorf."

"Matrox's ability to design and deliver innovative display hardware for medical imaging professionals is a perfect match with Totoku," says George Rigas, business development manager for medical imaging, Matrox Graphics Inc.

About Totoku

Totoku Electric Co., Ltd., a world's leading provider of advanced display systems for medical, industrial and commercial applications. Totoku has a network of subsidiaries and distributors in the world offering its reliable and high-quality products as well as dependable services and support. Founded in 1940, Totoku is headquartered in Tokyo, Japan and introduced its first medical LCD in 1999. For more information, visit http://www.totoku.eu.

About Matrox Graphics Inc.

Matrox Graphics is a leading manufacturer of graphics solutions for professional markets. In-house design expertise, top-to-bottom manufacturing, and dedicated customer support make our solutions the premier choice in industries that require stable, high-reliability products. Founded in 1976, Matrox is a privately held company headquartered in Montreal, Canada, with representation and offices in the Americas, Europe, and Asia. For more information, visit http://www.matrox.com/graphics.
CONTACT:

Donna Wong

514-822-6319

dwong@matrox.com


'/>"/>
SOURCE Matrox Graphics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
2. Pharmaxis Research Programs Highlighted at European Respiratory Society Congress
3. Kuvan Receives Positive Opinion From CHMP for European Approval
4. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
5. Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008
6. CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
7. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
8. ApoA-I Data Presented at European Society of Cardiology Congress
9. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
10. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
11. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... N.J. , May 4, 2016  Bayer ... its oncology compound Stivarga ® (regorafenib) tablets ... carcinoma (HCC) has met its primary endpoint of ... study, called RESORCE, evaluated the efficacy and safety ... has progressed after treatment with sorafenib. The safety ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nutrafol®, a first-to-market ... treat hormonal and stress related hair loss. With patent-pending formulas for both female ... opinion leaders in the medical and salon channels nationwide. , Dermatologists, Plastic ...
(Date:5/3/2016)... ... May 03, 2016 , ... Leading CEOs from ... May 31st and June 1st at The Four Seasons Hotel Boston. , The ... life sciences, offering exclusive access to key decision makers who influence deal making ...
(Date:5/3/2016)... 3, 2016 - And Other ... Producers of Those Competitor Biologics  - Biosimilar ... and Prospects ,  Who are the most ... what are their sales potentials? Discover, in our updated ... trends, opportunities and revenue forecasting. Visiongain,s ...
Breaking Biology Technology:
(Date:3/11/2016)... India , March 11, 2016 ... a new market research report "Image Recognition Market by ... Application (Marketing and Advertising), by Deployment Type (On-Premises and ... Forecast To 2022", published by MarketsandMarkets, the global market ... 2015 to USD 29.98 Billion by 2020, at a ...
(Date:3/9/2016)... , March 9, 2016 This BCC Research ... states of the RNA Sequencing (RNA Seq) market for ... as instruments, tools and reagents, data analysis, and services. ... segments of the RNA-Sequencing market such as RNA-Sequencing tools ... the main factors affecting each segment and forecast their ...
(Date:3/8/2016)... 2016   Valencell , the leading innovator ... has secured $11M in Series D financing. The ... venture fund being launched by UAE-based financial services ... investors TDF Ventures and WSJ Joshua Fund. Valencell ... triple-digit growth and accelerate its pioneering innovation in ...
Breaking Biology News(10 mins):